Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 28.84% is 263% above its 5-year average of 7.94%, near the high end of its 5-year range (0.36%–28.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 46.92% above its 12-month average of 19.63%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 28.84%.
DEBT TO ASSETS RATIO
28.84%
DEBT TO ASSETS RATIO AVG TTM
19.63%
DEBT TO ASSETS RATIO AVG 3Y
12.41%
DEBT TO ASSETS RATIO AVG 5Y
7.94%
DEBT TO ASSETS RATIO AVG 10Y
1.97%
DEBT TO ASSETS RATIO AVG 15Y
3.67%
DEBT TO ASSETS RATIO AVG 20Y
2.91%
CURRENT VS TTM AVG
+46.92%
CURRENT VS 3Y AVG
+132.50%
CURRENT VS 5Y AVG
+263.17%
CURRENT VS 10Y AVG
+1363.17%
CURRENT VS 15Y AVG
+686.29%
CURRENT VS 20Y AVG
+890.73%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+31949.90%
vs the sector median at left
Cocrystal Pharma, Inc.
Market Cap
$15.17M
Debt to Assets Ratio
28.84%
TTM Avg
19.63%
3Y Avg
12.41%
5Y Avg
7.94%
Market Cap
$15.36M
Debt to Assets Ratio
1.94%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.11M
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.65M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.71M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.57M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.01M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.93M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | $15.17M | 28.84% | 19.63% | 12.41% | 7.94% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.36M | 1.94% | N/A | N/A | N/A |
| Jin Medical International Ltd. (ZJYL)vs › | $15.11M | 0.37% | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.65M | 0.69% | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.71M | 0.00% | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 0.06% | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.57M | 0.34% | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.01M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.93M | 0.00% | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.55M | 0.77% | N/A | N/A | N/A |
Debt/Assets
28.8%
Debt/Equity
1.28
Current Ratio
1.24
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 28.84% |
| 2026-03-31 | 19.18% |
| 2025-12-31 | 15.50% |
| 2025-09-30 | 15.15% |
| 2025-06-30 | 19.49% |
| 2025-03-31 | 16.26% |
| 2024-12-31 | 13.42% |
| 2024-09-30 | 11.55% |
| 2024-06-30 | 8.25% |
| 2024-03-31 | 6.86% |
| 2023-12-31 | 5.93% |
| 2023-09-30 | 0.36% |
| 2023-06-30 | 0.49% |
| 2023-03-31 | 0.62% |
| 2022-12-31 | 0.73% |
| 2022-09-30 | 0.79% |
| 2022-06-30 | 0.80% |
| 2022-03-31 | 0.63% |
| 2021-12-31 | 0.67% |
| 2021-09-30 | 0.72% |
| 2021-06-30 | 0.55% |
| 2021-03-31 | 1.00% |
| 2020-12-31 | 1.10% |
| 2020-09-30 | 1.23% |
| 2020-06-30 | 1.74% |
| 2020-03-31 | 1.67% |
| 2019-12-31 | 2.86% |
| 2019-09-30 | 1.24% |
| 2019-06-30 | 1.34% |
| 2019-03-31 | 1.44% |
| 2018-12-31 | 0.48% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 1.69% |
| 2017-12-31 | 0.83% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 44.41% |
| 2013-09-30 | 68.25% |
| 2013-06-30 | 83.04% |
| 2013-03-31 | 85.46% |
| 2012-12-31 | 78.02% |
| 2012-09-30 | 52.49% |
| 2012-06-30 | 60.96% |
| 2012-03-31 | 67.87% |
| 2011-12-31 | 85.44% |
| 2011-09-30 | 67.46% |
| 2011-06-30 | 80.51% |
| 2011-03-31 | 98.42% |
| 2010-12-31 | 7720.45% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
